Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A stem cell-based approach for modelling implantation in vitro

Project description

A stem cell-based platform for modelling embryo implantation

The implantation is a complex and timely coordinated process of the first physical contact between the embryo and the uterus, which results in embryo attachment that is crucial for healthy pregnancy outcomes. Ability to manage embryo implantation has broad public health implications, including infertility treatment and contraception improvement. Funded by the Marie Skłodowska-Curie Actions programme, the IMPLANTATION project aims to apply single-cell sequencing, endometrial organoids and blastoid technologies to create a stem cell-based platform to simulate the blastocyst-uterus interaction and uncover molecular mechanisms mediating implantation. This platform will be accessible to high-throughput screening, gene editing, and live imaging, enabling the identification of the molecular regulators of implantation.

Objective

The first physical contact between the embryo and the uterus is a complex and timely coordinated process, which is crucial for positive pregnancy outcome. During that process of implantation, the embryo attaches and invades to nest into the uterus. Managing embryo implantation has wide implications for public health, including treating infertility (e.g. improving IVF outcomes) and for family planning (improving contraception). However, the tiny size of the embryo and inaccessibility into the womb make implantation a true black box in developmental biology. Three technological breakthroughs, i.e. single cell sequencing, endometrial organoids and blastoid technologies, now made it possible to deeply and finely investigate implantation. Here, I aim at leveraging these technologies to create a stem cell-based platform to model the blastocyst-uterus interaction and to reveal molecular mechanisms mediating implantation. This platform will be amenable to high-throughput screening, gene editing, and live imaging, to identify the molecular regulators of implantation. If successful, this study will provide a biologically relevant, easily accessible and experimentally amenable system to perform in-depth studies with scientific and clinical impacts to understand and potentially treat conditions such as infertility, reproductive decline, develop novel contraceptive and in the long term, to develop drugs to improve reproductive health and prevent several chronic diseases.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-IF-2020

See all projects funded under this call

Coordinator

INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE GMBH
Net EU contribution
€ 174 167,04
Address
DR BOHRGASSE 3
1030 Wien
Austria
Region
Ostösterreich Wien Wien
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
€ 174 167,04